Endocrinology, Metabolism, and Diabetes

2/6/16
Ajay Chaudhuri, MD, clinical professor of medicine and medical director of the Diabetes-Endocrinology Center of Western New York, says he wants Western New Yorkers to be optimistic about diabetes and what can be done to prevent and treat the condition.
1/25/16
Research led by Paresh Dandona, MD, PhD, Distinguished Professor of Medicine and chief of endocrinology, shows that boosting testosterone can significantly benefit many men with Type 2 diabetes.
7/2/15
Amy L. O’Donnell, MD, associate professor of medicine, provides insight on veterans’ risk factors for diabetes and discusses common conditions she sees in the endocrinology clinic at the Buffalo VA Medical Center. She also explains the endocrine system and advises on treatments for patients facing diabetes. 
5/15/15
A news story about three diabetes drugs that have been linked to ketoacidosis refers to research led by Nitesh D. Kuhadiya, MD, clinical assistant professor of medicine. In a trial of 10 type 1 diabetes patients on insulin, liraglutide and dapagliflozin, one of the patients developed diabetic ketoacidosis, according to the research.
3/10/15
Combination therapy with Vytorin to treat high cholesterol and triglyceride levels in the blood appears to provide an anti-inflammatory effect and reduce proinflammatory mediators after consumption of fatty foods, according to research by Paresh Dandona, MD, PhD, UB Distinguished Professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism.
10/2/14
Corticosteroids — long prescribed for their anti-inflammatory effects — also have certain pro-inflammatory effects at high doses, according to a study led by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism.
9/18/14
UB endocrinology expert Paresh Dandona, MD, PhD, contributes his expertise in an article on the FDA advisory committees’ vote in favor of revising the current indication for testosterone replacement therapies.
6/19/14
According to findings by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, Type 2 diabetic men with hypogonadotropic hypogonadism had a significant 25 percent increase in insulin sensitivity after taking testosterone injections for six months.
6/19/14
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, says the drug Dulaglutide has properties of reducing blood glucose concentrations, suppressing appetite and causing weight loss. “We’d like to see more data on whether this drug also causes blood pressure fall,” he says. 
6/9/14
Manav Batra, MBBS, clinical assistant professor of medicine, says his research shows — for the first time — that men with type 2 diabetes and hypogonadotropic hypogonadism are more insulin resistant as compared to men who have normal testosterone.
2/26/14
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, cites growing evidence that suggests liraglutide, already used for Type 2 diabetes, may aid weight loss.
2/3/14
An article about the health consequences of sugar cites research by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine, which shows that excess sugar in the blood increases the production of free radicals.
2/1/14
Over more than a decade, groundbreaking research by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine, has demonstrated that insulin is an anti-inflammatory hormone and may be cardioprotective.
7/26/13
In collaboration with other researchers, Paresh Dandona, MD, PhD, of the Department of Medicine, has found numerous biological connections between asthma and obesity.
7/25/13
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine, led two interrelated studies that uncover several biological ties between obesity and asthma.